Characterization of cytoskeleton-enriched protein fraction of the trabecular meshwork and ciliary muscle cells

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6461-6471

  Inoue, Toshihiro ^a,b   Pecen, Paula ^a   Maddala, Rupalatha ^a   Skiba, Nikolai P ^a   Pattabiraman, Padmanabhan P ^a   Epstein, David L ^a   Vasantha Rao, P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ACTININ; CALDESMON; CLATHRIN; CYTOSKELETON PROTEIN; F ACTIN; FILAMIN A; GAMMA ACTIN; LIPOCORTIN 2; MYOSIN I; MYOSIN IC; MYOSIN II; MYOSIN IIA; MYOSIN LIGHT CHAIN KINASE; PLECTIN; PLECTIN 1; RHO KINASE; STOMATIN; UNCLASSIFIED DRUG; VIMENTIN;

ACTIN STRESS FIBER; ANIMAL CELL; ARTICLE; CELL SHAPE; CILIARY MUSCLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; STRESS FIBER; SWINE; TRABECULAR MESHWORK; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANIMALS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CILIARY BODY; CYTOSKELETAL PROTEINS; CYTOSKELETON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; MIDDLE AGED; MUSCLE, SMOOTH; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; NONMUSCLE MYOSIN TYPE IIA; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; SWINE; TRABECULAR MESHWORK;

EID: 79955960232     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5318     Document Type: Article

References (61)

1. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005;24:612-637.
2. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
3. Rao PV, Epstein DL. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. BioDrugs. 2007;21:167-177.
4. Brubaker RF. The effect of intraocular pressure on conventional outflow resistance in the enucleated human eye. Invest Ophthalmol. 1975;14:286-292.
5. Johnson M. What controls aqueous humour outflow resistance? Exp Eye Res. 2006;82:545-557.
6. Johnstone MA. The aqueous outflow system as a mechanical pump: evidence from examination of tissue and aqueous movement in human and non-human primates. J Glaucoma. 2004;13:421-438.
7. Borras T, Rowlette LL, Tamm ER, Gottanka J, Epstein DL. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Invest Ophthalmol Vis Sci. 2002;43:33-40.
8. Hashimoto JM, Epstein DL. Influence of intraocular pressure on aqueous outflow facility in enucleated eyes of different mammals. Invest Ophthalmol Vis Sci. 1980;19:1483-1489.
9. Wiederholt M, Thieme H, Stumpff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res. 2000;19:271-295.
10. Tamm ER. The trabecular meshwork outflow pathways: structural and functional aspects. Exp Eye Res. 2009;88:648-655.
11. Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS. Extracellular matrix turnover and outflow resistance. Exp Eye Res. 2009;88:676-682.
12. Tian B, Gabelt BT, Geiger B, Kaufman PL. The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res. 2009;88:713-717.
13. Tumminia SJ, Mitton KP, Arora J, Zelenka P, Epstein DL, Russell P. Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1998;39:1361-1371.
14. Tian B, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
15. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40:74-81.
16. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
17. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
18. Khurana RN, Deng PF, Epstein DL, Vasantha Rao P. The role of protein kinase C in modulation of aqueous humor outflow facility. Exp Eye Res. 2003;76:39-47.
19. Honjo M, Inatani M, Kido N, et al. A myosin light chain kinase inhibitor, ML-9, lowers the intraocular pressure in rabbit eyes. Exp Eye Res. 2002;75:135-142.
20. Cvekl A, Tamm ER. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays. 2004;26:374-386.
21. Gage PJ, Zacharias AL. Signaling "cross-talk" is integrated by transcription factors in the development of the anterior segment in the eye. Dev Dyn. 2009;238:2149-2162.
22. Wiederholt M, Schafer R, Wagner U, Lepple-Wienhues A. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger J Ophthalmol. 1996;5:146-153.
23. Wiederholt M. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr Opin Ophthalmol. 1998;9:46-49.
24. Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 2004;45:2263-2271.
25. Tamm E, Flugel C, Baur A, Lutjen-Drecoll E. Cell cultures of human ciliary muscle: growth, ultrastructural and immunocytochemical characteristics. Exp Eye Res. 1991;53:375-387.
26. Rao PV, Ho T, Skiba NP, Maddala R. Characterization of lens fiber cell triton insoluble fraction reveals ERM (ezrin, radixin, moesin) proteins as major cytoskeletal-associated proteins. Biochem Biophys Res Commun. 2008;368:508-514.
27. de Kater AW, Shahsafaei A, Epstein DL. Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1992;33:424-429.
28. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6:1034-1038.
29. Popowicz GM, Schleicher M, Noegel AA, Holak TA. Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci. 2006;31:411-419.
30. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol. 2005;6:449-461.
31. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83:1325-1358.
32. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
33. Gipson IK, Anderson RA. Actin filaments in cells of human trabecular meshwork and Schlemm's canal. Invest Ophthalmol Vis Sci. 1979;18:547-561.
34. Grierson I, Rahi AH. Microfilaments in the cells of the human trabecular meshwork. Br J Ophthalmol. 1979;63:3-8.
35. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005;60:83-95.
36. Erickson-Lamy K, Schroeder A, Epstein DL. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci. 1992;33:2631-2640.
37. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Nonmuscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 2009;10:778-790.
38. Cai Y, Sheetz MP. Force propagation across cells: mechanical coherence of dynamic cytoskeletons. Curr Opin Cell Biol. 2009;21:47-50.
39. Clark K, Langeslag M, Figdor CG, van Leeuwen FN. Myosin II and mechanotransduction: a balancing act. Trends Cell Biol. 2007;17:178-186.
40. Zhang M, Rao PV. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Invest Ophthalmol Vis Sci. 2005;46:4130-4138.
41. Rao PV, Deng P, Sasaki Y, Epstein DL. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res. 2005;80:197-206.
42. Gabelt BT, Hu Y, Vittitow JL, et al. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res. 2006;82:935-944.
43. Leung CL, Green KJ, Liem RK. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol. 2002;12:37-45.
44. Ruhrberg C, Watt FM. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev. 1997;7:392-397.
45. Stossel TP, Condeelis J, Cooley L, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2:138-145.
46. Shifrin Y, Arora PD, Ohta Y, Calderwood DA, McCulloch CA. The role of FilGAP-Filamin A interactions in mechanoprotection. Mol Biol Cell. 2009;20:1269-1279.
47. Yamazaki M, Furuike S, Ito T. Mechanical response of single Filamin A (ABP-280) molecules and its role in the actin cytoskeleton. J Muscle Res Cell Motil. 2002;23:525-534.
48. D'Addario M, Arora PD, Fan J, Ganss B, Ellen RP, McCulloch CA. Cytoprotection against mechanical forces delivered through beta 1 integrins requires induction of Filamin A. J Biol Chem. 2001;276:31969-31977.
49. D'Addario M, Arora PD, Ellen RP, McCulloch CA. Interaction of p38 and Sp1 in a mechanical force-induced, beta 1 integrin-mediated transcriptional circuit that regulates the actin-binding protein filamin-A. J Biol Chem. 2002;277:47541-47550.
50. Glogauer M, Arora P, Chou D, Janmey PA, Downey GP, McCulloch CA. The role of actin-binding protein 280 in integrin-dependent mechanoprotection. J Biol Chem. 1998;273:1689-1698.
51. Kainulainen T, Pender A, D'Addario M, Feng Y, Lekic P, McCulloch CA. Cell death and mechanoprotection by filamin a in connective tissues after challenge by applied tensile forces. J Biol Chem. 2002;277:21998-22009.
52. Pavalko FM, Otey CA, Simon KO, Burridge K. Alpha-actinin: a direct link between actin and integrins. Biochem Soc Trans. 1991;19:1065-1069.
53. Burridge K, Feramisco JR. Non-muscle alpha actinins are calciumsensitive actin-binding proteins. Nature. 1981;294:565-567.
54. Viel A. Alpha-actinin and spectrin structures: an unfolding family story. FEBS Lett. 1999;460:391-394.
55. Sokac AM, Schietroma C, Gundersen CB, Bement WM. Myosin-1c couples assembling actin to membranes to drive compensatory endocytosis. Dev Cell. 2006;11:629-640.
56. Matsumoto Y, Johnson DH. Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest Ophthalmol Vis Sci. 1997;38:1902-1907.
57. Zhou L, Li Y, Yue BY. Alteration of cytoskeletal structure, integrin distribution, and migratory activity by phagocytic challenge in cells from an ocular tissue-the trabecular meshwork. In Vitro Cell Dev Biol Anim. 1999;35:144-149.
58. Hardy KM, Hoffman EA, Gonzalez P, McKay BS, Stamer WD. Extracellular trafficking of myocilin in human trabecular meshwork cells. J Biol Chem. 2005;280:28917-28926.
59. Morel E, Gruenberg J. Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation. J Biol Chem. 2009;284:1604-1611.
60. Hajjar KA, Krishnan S. Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med. 1999;9:128-138.
61. Faure AV, Migne C, Devilliers G, Ayala-Sanmartin J. Annexin 2 "secretion" accompanying exocytosis of chromaffin cells: possible mechanisms of annexin release. Exp Cell Res. 2002;276:79-89.